quinone methide has been researched along with Neoplasms in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alho, DPS; Figueiredo, SAC; Gonçalves, BMF; Leal, AS; Mendes, VIS; Salvador, JAR; Silvestre, SM; Valdeira, AS | 1 |
| Anraku, Y; Dirisala, A; Ge, Z; Kataoka, K; Ke, W; Li, J; Matsumoto, Y; Osada, K; Toh, K; Wang, Y; Xie, J; Yin, W | 1 |
| Bindoli, A; Citta, A; Folda, A; Jaouen, G; Pigeon, P; Rigobello, MP; Salmain, M; Top, S; Vessières, A | 1 |
| Estévez-Braun, A; Lacal, JC; Pérez-Sacau, E; Ravelo, AG | 1 |
| Basarić, N; Kralj, M; Mlinarić-Majerski, K; Piantanida, I; Tireli, M; Uzelac, L; Wan, P; Wang, YH | 1 |
| Ashworth-Sharpe, J; Bieniarz, C; Kelly, BD; Polaske, NW | 1 |
| Dufrasne, F; Gelbcke, M; Kiss, R; Kraus, JL; Neve, J | 1 |
| Amir, RJ; Gopin, A; Pessah, N; Shabat, D; Shamis, M | 1 |
3 review(s) available for quinone methide and Neoplasms
| Article | Year |
|---|---|
Oleanane-, ursane-, and quinone methide friedelane-type triterpenoid derivatives: Recent advances in cancer treatment.
Topics: Animals; Antineoplastic Agents; Chemistry Techniques, Synthetic; Humans; Indolequinones; Neoplasms; Oleanolic Acid; Structure-Activity Relationship; Triterpenes | 2017 |
Quinone methides and their prodrugs: a subtle equilibrium between cancer promotion, prevention, and cure.
Topics: Animals; Humans; Indolequinones; Neoplasms; Prodrugs; Quinones | 2011 |
Chemical adaptor systems.
Topics: Antineoplastic Agents; Cross-Linking Reagents; Cyclization; Drug Delivery Systems; Drug Design; Indolequinones; Macromolecular Substances; Molecular Structure; Neoplasms | 2004 |
5 other study(ies) available for quinone methide and Neoplasms
| Article | Year |
|---|---|
Therapeutic Vesicular Nanoreactors with Tumor-Specific Activation and Self-Destruction for Synergistic Tumor Ablation.
Topics: Antineoplastic Agents; Antioxidants; Boronic Acids; Cell Death; Cell Membrane Permeability; Drug Carriers; Esters; Glucose Oxidase; Glutathione; Humans; Hydrogen Peroxide; Hydrogen-Ion Concentration; Indolequinones; Methacrylates; Microscopy, Electron, Transmission; Nanostructures; Neoplasms; Piperidines; Polyethylene Glycols; Proof of Concept Study | 2017 |
Evidence for targeting thioredoxin reductases with ferrocenyl quinone methides. A possible molecular basis for the antiproliferative effect of hydroxyferrocifens on cancer cells.
Topics: Animals; Antineoplastic Agents; Cystamine; Ferrous Compounds; Glutathione; Glutathione Reductase; Humans; Indolequinones; Inhibitory Concentration 50; Jurkat Cells; Metallocenes; Neoplasms; Organoselenium Compounds; Rats; Selenocysteine; Thioredoxin-Disulfide Reductase | 2014 |
A new family of choline kinase inhibitors with antiproliferative and antitumor activity derived from natural products.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Arthritis, Rheumatoid; Biological Products; Cell Line, Tumor; Cell Proliferation; Choline Kinase; HT29 Cells; Humans; Indolequinones; Inhibitory Concentration 50; Maximum Tolerated Dose; Mice; Mice, Nude; Molecular Docking Simulation; Neoplasm Transplantation; Neoplasms; Phosphatidylcholines; Recombinant Proteins; Triterpenes | 2015 |
Enhancement of antiproliferative activity by phototautomerization of anthrylphenols.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Humans; Indolequinones; Inhibitory Concentration 50; Isomerism; Molecular Structure; Neoplasms; Photochemical Processes | 2015 |
Quinone Methide Signal Amplification: Covalent Reporter Labeling of Cancer Epitopes using Alkaline Phosphatase Substrates.
Topics: Alkaline Phosphatase; Epitopes; Humans; Indolequinones; Microscopy, Fluorescence; Neoplasms; Substrate Specificity | 2016 |